1.0500
+0.0200
+(1.94%)
At close: January 17 at 6:29:31 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,683.0000
4,025.0000
4,599.0000
9,071.0000
10,062.0000
Cost of Revenue
-884.0000
-958.0000
-1,666.0000
-718.0000
-603.0000
Gross Profit
4,567.0000
4,983.0000
6,265.0000
9,789.0000
10,665.0000
Operating Expense
15,760.0000
17,116.0000
14,058.0000
10,542.0000
5,952.0000
Operating Income
-11,193.0000
-12,133.0000
-7,793.0000
-753.0000
4,713.0000
Net Non Operating Interest Income Expense
438.0000
271.0000
-759.0000
-4,309.0000
-96.0000
Pretax Income
-10,754.0000
-11,860.0000
-8,552.0000
-5,063.0000
4,616.0000
Tax Provision
-501.0000
1.0000
--
-1.0000
884.0000
Net Income Common Stockholders
-10,755.0000
-11,861.0000
-8,552.0000
-5,061.0000
3,732.0000
Diluted NI Available to Com Stockholders
-10,755.0000
-11,861.0000
-8,552.0000
-5,061.0000
3,732.0000
Basic EPS
-0.25
-0.28
-0.20
-0.15
0.09
Diluted EPS
-0.25
-0.28
-0.20
-0.15
0.09
Basic Average Shares
43,437.3970
42,360.7140
42,760.0000
33,740.0000
42,616.9360
Diluted Average Shares
43,437.3970
42,360.7140
42,760.0000
33,740.0000
42,616.9360
Total Operating Income as Reported
-11,194.0000
-12,132.0000
-7,792.0000
-753.0000
4,712.0000
Total Expenses
14,876.0000
16,158.0000
12,392.0000
9,824.0000
5,349.0000
Net Income from Continuing & Discontinued Operation
-10,755.0000
-11,861.0000
-8,552.0000
-5,061.0000
3,732.0000
Normalized Income
-10,755.0000
-11,861.0000
-8,552.0000
-5,061.0000
3,732.0000
Interest Income
541.0000
246.0000
25.0000
7.0000
14.0000
Interest Expense
982.0000
154.0000
130.0000
162.0000
74.0000
Net Interest Income
438.0000
271.0000
-759.0000
-4,309.0000
-96.0000
EBIT
-10,292.0000
-11,706.0000
-8,422.0000
-4,901.0000
4,690.0000
EBITDA
-5,904.0000
-8,113.0000
-6,565.0000
-3,687.0000
5,765.0000
Reconciled Cost of Revenue
-884.0000
-958.0000
-1,666.0000
-718.0000
-603.0000
Reconciled Depreciation
4,388.0000
3,593.0000
1,857.0000
1,214.0000
1,075.0000
Net Income from Continuing Operation Net Minority Interest
-10,755.0000
-11,861.0000
-8,552.0000
-5,061.0000
3,732.0000
Normalized EBITDA
-5,904.0000
-8,113.0000
-6,565.0000
-3,687.0000
5,765.0000
Tax Rate for Calcs
--
0.0002
--
0.0000
0.0002
12/31/2020 - 9/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BONEH.HE BBS-Bioactive Bone Substitutes Oyj
0.0666
-0.89%
0TN.F Bioretec Oy
2.3000
+1.32%
BRETEC.HE Bioretec Oy
2.3600
0.00%
NXTMH.HE Nexstim Plc
9.12
-1.08%
REG1V.HE Revenio Group Oyj
28.18
+3.00%
BICO.ST BICO Group AB (publ)
34.40
+11.91%
BVS Bioventus Inc.
10.04
-0.69%
SMLR Semler Scientific, Inc.
64.68
+11.06%